Table 1 Clinical characteristics of study population
Variables | CAD group (n = 911) | Control group (n = 322) | P |
|---|---|---|---|
Male [n (%)] | 605(66.40) | 214(66.46) | 0.987 |
Age (years) | 64.51 ± 12.21 | 62.98 ± 13.34 | 0.064 |
Smoking [n (%)] | 274(30.10) | 42(13.04) | < 0.001 |
Alcohol drinking [n (%)] | 138(15.10) | 35(10.87) | 0.057 |
Hypertension [n (%)] | 486(53.30) | 144(44.72) | 0.008 |
Diabetes [n (%)] | 206(22.60) | 27(8.39) | < 0.001 |
Fasting blood glucose (mmol/L) | 6.33 ± 2.50 | 4.91 ± 0.58 | < 0.001 |
Total cholesterol (mmol/L) | 4.25 ± 1.04 | 3.87 ± 0.88 | < 0.001 |
Triglycerides (mmol/L) | 1.69 ± 1.12 | 1.14 ± 0.37 | < 0.001 |
High-density lipoprotein (mmol/L) | 1.03 ± 0.28 | 1.10 ± 0.30 | < 0.001 |
Low-density lipoprotein (mmol/L) | 2.60 ± 0.91 | 2.25 ± 0.73 | < 0.001 |
Neutrophil count (10^9/L) | 5.82 ± 2.91 | 3.97 ± 2.03 | < 0.001 |
Lymphocyte count (10^9/L) | 1.58 ± 0.94 | 1.65 ± 0.57 | 0.149 |
Monocyte count (10^9/L) | 0.50 ± 0.24 | 0.41 ± 0.16 | < 0.001 |
Platelet count (10^9/L) | 214.69 ± 62.11 | 212.90 ± 61.80 | 0.657 |
Albumin (g/L) | 40.50 ± 4.47 | 41.92 ± 3.76 | < 0.001 |
Fibrinogen (g/L) | 3.12 ± 0.95 | 2.81 ± 0.84 | < 0.001 |